GSK-Galapagos' autoimmune disease drug enters midstage trials

02/6/2013 | Pharmaceutical Business Review Online · Reuters

GlaxoSmithKline is preparing midstage trials to assess the experimental drug GSK2586184 in patients with systemic lupus erythematosus and chronic plaque psoriasis. GSK2586184, a selective JAK1 molecule, was identified under Galapagos and GSK's osteoarthritis collaboration.

View Full Article in:

Pharmaceutical Business Review Online · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX